Locally delivered GLP-1 analogues liraglutide and exenatide enhance microvascular perfusion in individuals with and without type 2 diabetes

AIMS/HYPOTHESIS: Glucagon-like peptide-1 (GLP-1) analogues reduce the risk of macrovascular disease in diabetes; however, little is known about their microvascular effects. This research examined the microvascular actions of the GLP-1 analogues liraglutide and exenatide in individuals with and witho...

Descripción completa

Detalles Bibliográficos
Autores principales: Aung, Myo Myo, Slade, Kate, Freeman, Leighton A. R., Kos, Katarina, Whatmore, Jacqueline L., Shore, Angela C., Gooding, Kim M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6677680/
https://www.ncbi.nlm.nih.gov/pubmed/31203378
http://dx.doi.org/10.1007/s00125-019-4918-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6677680/
https://www.ncbi.nlm.nih.gov/pubmed/31203378
http://dx.doi.org/10.1007/s00125-019-4918-x

Ejemplares similares